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Although alcohol is not known to be carcinogenic in animal exper-
imentation, there is strong epidemiological evidence that alcoholic
beverages increase the risk of cancers of the oral cavity and
pharynx, oesophagus and larynx. The risks are essentially due to
total ethanol intake, and tend to increase with the amount of
ethanol drunk, but it is still unclear whether there is any threshold
below which no effect is evident (IARC, 1988; Doll et al, 1999).
Alcohol drinking has been associated with primary liver cancer,
although this relation is difficult to investigate in epidemiological
studies, since most alcohol-related liver cancers follow a cirrhosis,
which leads to a reduction of alcohol drinking (Aricò et al, 1994;
La Vecchia et al, 1998). 
Alcohol drinking has also been linked to cancers of the large
bowel in both sexes and of the female breast. Although these asso-
ciations are still open to discussion, these are the 2 most common
neoplasms in developed countries after lung cancer, and therefore
even a moderate excess risk may have important public health
implications. The association between alcohol drinking and
several other neoplasms, including ovary, endometrium and
bladder, is still controversial (IARC, 1988; Doll et al, 1999). 
To evaluate the effect of alcohol on cancer risk, a more accu-
rate quantification of its effects on various neoplasms is required.
With this major focus, we therefore updated in the present paper
a comprehensive meta-analysis of published case–control and
cohort studies investigating the possible relation between alcohol
intake and the risk of several neoplasm (Corrao et al, 1999). We
also addressed the issue of the potential modifying effect of
tobacco on alcohol-related cancerogenesis at various cancer
sites. 
METHODS 
The statistical methods used for this meta-analysis are described in
detail elsewhere (Corrao et al, 1999, 2000). Articles included were
found through a search of the literature published from 1966 to
2000. The search was based on several bibliographic data-bases
(MEDLINE, Current Contents, EMBASE, CAB Abstracts and
Core Biomedical Collection), supplemented by checking all refer-
ences in the selected articles. Completeness was verified by a
hand-search on the most relevant journals of epidemiology and
medicine, and by comparing our search with that of general
reviews and meta-analyses published on this issue (IARC, 1988;
Longnecker et al, 1990; Longnecker, 1994, 1995; Longnecker and
Enger, 1996; Corrao et al, 1999; Doll et al, 1999; Zeegers et al,
1999; Dennis, 2000). 
Each publication identified by this process was reviewed and
included in the analysis if the following criteria were met:
(i) case–control or cohort study published as an original article;
(ii) findings expressed as odds ratio or relative risk (RR), cons-
idering at least 3 levels of alcohol consumption; (iii) papers
reporting the number of cases and non-cases, and the estimates of
the odds ratios or RR for each exposure level. Multivariate RRs
were used for the main analysis purpose. When the results of a
study were published more than once, only the most complete data
were included in the analysis. 
2 readers, blinded to the authors’ names and affiliations and to
the results pertaining to alcohol consumption, independently
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determined the eligibility of each paper. Pooled estimates of the
effect of alcohol consumption on the risk of each neoplasm 
investigated were based on several meta-regression models
(Greenland and Longnecker, 1992). Briefly, the data analysis
strategy first involved pooling the original data for each
neoplasm; subsequently the relationship between alcohol
consumption and risk was modelled by fitting several fractional
models (Royston et al, 1999) in order to identify J- or U-shaped
curves, or other relations between alcohol exposure level and
relative risks. In the current application, a family of second-order
models was generated by power transformation of exposure vari-
able, and the best-fitting model was chosen to summarise the rela-
tion of interest. The effects of gender and of the adjustment of the
reported estimates for smoking in modifying the effect of alcohol
on the risk of each neoplasm were also investigated by comparing
pooled estimates based on RRs unadjusted for tobacco to the
adjusted ones used in the main analysis, whenever available
(Berlin et al, 1993). Heterogeneity among studies was evaluated
according to the method described by Greenland and Longnecker
(1992). 
RESULTS 
Altogether, 235 studies with a total of 117 471 cases, met the
inclusion criteria and were considered in the analysis. Of the
included studies, 187 were case–control and 48 cohort studies,
investigating the risk of 18 cancer sites, or of all cancers irrespec-
tive of site. 
The main characteristics and results of the studies, based 
on multivariate analysis, are given in Table 1. For 5 cancer 
sites (melanoma and cancer of small intestine, gallbladder,
cervix uteri and kidney) the estimates were based on one or 2
studies only, and did not consider the effects of high alcohol
consumption. 
Strong direct trends in risk were observed for cancers of the oral
cavity and pharynx (RR = 6.0 for 100 g day–1), oesophagus (RR =
4.2) and larynx (RR = 3.9). Direct relations – though appreciably
less strong – were also found for cancers of the stomach (RR =
1.32), colo-rectum (RR = 1.38) and liver (RR = 1.86), as well as
for breast (RR = 1.7 for 50 g day–1 and 2.7 for 100 g day–1) and
ovarian (RR = 1.53) neoplasms. Weaker trends were found for
lung (RR = 1.08) and prostate (RR = 1.19) cancers. For most
cancer sites, significant increased risks were found also for the
lowest dose of alcohol considered (25 g day–1, corresponding to
approximately 2 drinks per day). No significant relation emerged
between alcohol and pancreas, endometrium and bladder cancers. 
Significant heterogeneity across studies was found. Effects of
gender in modifying the effect of alcohol intake were investigated
for each cancer site, but reached statistical significance only for
oesophageal and liver cancers, with higher risks in women for both
neoplasms. By pooling the 8 studies reporting the relation between
alcohol and the risk of all sites together, significant effects were
found starting from intakes of 28 g day–1. 
To analyse the modifying effect of tobacco, pooled estimates
based on unadjusted and adjusted RRs were compared in Table 2
for studies providing relevant information. Effects of smoking
adjustment in modifying the effect of alcohol related risks were
investigated for 5 neoplasms known to be strongly tobacco-
related, but reached statistical significance only for cancers of
larynx, lung and bladder, with higher risks for unadjusted 
estimates. However, while for laryngeal cancer evidence of a
substantial alcohol-related risk persisted by pooling studies
reporting both unadjusted and adjusted estimates, alcohol did not
show significant effects on the risk of lung and bladder neoplasms
when its effect was adjusted for smoking. Allowance for tobacco
had a negligible effect on the estimates for colorectal cancer.
Figure 1 gives the relative risk functions for alcohol consumption,
and the corresponding 95% CI of selected neoplasms, by fitting
meta-regression models. 
DISCUSSION 
This work has some of the limitations, but also most of the
strengths of meta-analyses of published studies, including the
large number of subjects investigated and the comprehensive
picture provided. Its main results are consistent with published
meta analyses on alcohol and breast, colorectal (Longnecker et al,
1990; Longnecker, 1994, 1995), bladder (Zeegers et al, 1999) and
prostate (Dennis, 2000) cancers. 
For most neoplasms considered, estimates tended to be hetero-
geneous across studies. Consequently, the overall pooled estimates
may be systematically influenced by characteristics of the subjects
included such as gender, due to the potential differences in alcohol
metabolism in women and men (Corrao et al, 1999, 2000). To
control for this, whenever possible we included gender term in the
meta-regression models. However, gender explained a significant
part of the observed heterogeneity only for cancers of oesophagus
and liver. 
Another open issue is the definition of former drinkers, which in
some studies may include only a fraction of former drinkers.
However, the time-risk relations between alcohol drinking and
cancer risk are complex (Bosetti et al, 2000; Franceschi et al,
2001) and misclassification of former smokers should, if anything,
have led to an underestimate of the real association. Further,
several cohort studies may have selectively reported relevant find-
ings for selected cancer sites only, and omitted data for less
common ones. 
It is likely, moreover that alcohol drinking was systematically
under-reported in several studies, mostly for selected neoplasms.
Consequently, all the RRs would be biased towards lower levels
of drinking in case of non-selective under-reporting, or underesti-
mated in the case of selective under-reporting by cases. Specific
perplexities concern the pooled estimates for liver cancer, due to
pre-existing cirrhosis and consequent reduced alcohol consump-
tion (Aricò et al, 1994; La Vecchia et al, 1998). Further, although
this meta-analysis included a total of over 117 000 cases, absolute
numbers were relatively limited for some diseases (melanoma,
uterus and kidney cancers) or for certain levels of alcohol
drinking (high levels for breast cancer in women). Finally,
confounding might affect our pooled estimates. However, esti-
mates in the main analysis for upper digestive and respiratory
tract cancers, as well as for lung and bladder neoplasms, were
adjusted for tobacco, which showed a substantial modifying
effect not only for lung and bladder, but also for laryngeal cancer.
The moderate excess risk for lung and bladder cancer, moreover,
may well be due to some residual confounding by tobacco. No
relevant modifying effect was observed for colorectal cancer,
which appears to be another tobacco-related neoplasm – though
less strongly than the above mentioned ones (D’Avanzo et al,





































































































Table 1 Main characteristics of the studies selected for the meta-analysis. Pooled relative risks, and corresponding 95% confidence interval, for selected doses of alcohol consumption are also reported 
Number Study’s design Pooled RR (and 95% CI) associated with alcohol intakea Gender Heterogeneity 
Malignancy site Studies Cases Cohort Case–control 25 g day–1 50 g day–1 100 g day–1 effect (P)b test (P)c
Oral cavity and pharynx 26 7954 1 25 1.75 (1.70, 1.82) 2.85 (2.70, 3.04) 6.01 (5.46, 6.62) n.s. < 0.05 
Oesophagus 28 7239 1 27 1.51 (1.48, 1.55) 2.21 (2.11, 2.31) 4.23 (3.91, 4.59) < 0.05 < 0.05 
Males 18 3310 1 17 1.43 (1.38, 1.48) 1.98 (1.87, 2.11) 3.49 (3.14, 3.89) – < 0.05 
Females 5 304 0 5 1.52 (1.42, 1.63) 2.24 (1.95, 2.58) 4.45 (3.37, 5.87)
Stomach 16 4518 2 14 1.07 (1.04, 1.10) 1.15 (1.09, 1.22) 1.32 (1.18, 1.49) n.s. < 0.05 
Small intestine 2 415 0 2 1.02 (0.89, 1.17) 1.04 (0.79, 1.37) 1.08 (0.63, 1.88) n.s. n.s.
Colon and rectum 22 11 296 6 16 1.08 (1.06, 1.10) 1.18 (1.14, 1.22) 1.38 (1.29, 1.49) n.s. < 0.05 
Liver 20 2294 3 17 1.17 (1.11, 1.23) 1.36 (1.23, 1.51) 1.86 (1.53, 2.27) < 0.05 < 0.05 
Males 10 949 2 8 1.28 (1.13, 1.45) 1.51 (1.27, 2.10) 1.62 (1.18, 2.24) – < 0.05 
Females 3 231 1 2 1.97 (1.30, 3.00) 3.57 (1.56, 8.21) 9.15 (1.73, 48.41)
Gallbladder 2 81 1 1 1.17 (0.73, 1.86) 1.36 (0.54, 3.44) d n.s. n.s.
Pancreas 17 2524 4 13 0.98 (0.90, 1.05) 1.05 (0.93, 1.18) 1.18 (0.94, 1.49) n.s. < 0.05 
Larynx 20 3759 0 20 1.38 (1.32, 1.45) 1.94 (1.78, 2.11) 3.95 (3.43, 4.57) n.s. < 0.05 
Lung 6 2314 3 3 1.02 (1.00, 1.04) 1.04 (1.00, 1.08) 1.08 (1.00, 1.18) n.s. < 0.05 
Melanoma 2 708 0 2 0.50 (0.21, 1.10) dd n.s. n.s.
Breast 49 44 033 12 37 1.31 (1.27, 1.36) 1.67 (1.56, 1.78) 2.71 (2.33, 3.08) – < 0.05 
Cervix 1 242 – 1 0.80 (0.50, 1.27) 0.64 (0.25, 1.60) –– 0.53 
Endometrium 6 2473 2 4 1.05 (0.88, 1.24) 1.09 (0.78, 1.54) 1.20 (0.60, 2.37) – < 0.01 
Ovary 5 1651 – 5 1.11 (1.00, 1.24) 1.23 (1.01, 1.54) 1.53 (1.03, 2.32) – n.s.
Prostate 11 4094 4 7 1.05 (1.00, 1.08) 1.09 (1.02, 1.17) 1.19 (1.03, 1.37) – n.s. 
Bladder 11 5997 2 9 1.04 (0.99, 1.09) 1.08 (0.98, 1.19) 1.17 (0.97, 1.41) n.s. n.s. 
Kidney 2 921 0 2 0.88 (0.77, 1.02) 0.79 (0.60, 1.03) 0.62 (0.36, 1.06) n.s. n.s.
All sites together 8 14 495 6 2 1.01 (0.90, 1.05) 1.22 (1.11, 1.27) 1.91 (1.77, 2.06) n.s. < 0.05 
Total 235 117 471 48 187 –– – – –  
aPooled relative risk, and corresponding 95% confidence interval (CI), based on multivariate estimates, directly obtained from the β coefficients of the best fitting model, and from the corresponding standard error,
respectively (see Methods section); Evidence of a relative risk significantly different from 1 based on 95% CI that does not contain unity (P < 0.05). bEvidence of significant effect of gender in modifying the effect of
alcohol based on significance of the interaction term (P < 0.05). cSignificance (P < 0.05) indicates heterogeneity of the effects of alcohol among studies. dNo studies reported effect of alcohol at the specific dose. Alcohol and cancer 1703
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The results were generally inconsistent for cancer of the
pancreas, stomach and colorectum, and somewhat inconsistent
across studies, possibly following differences in their design.
There is also no clear understanding on the possible underlying
mechanisms through which alcohol may act as a co-carcinogen on
these sites (IARC, 1988; Doll et al, 1999). More importantly, the
pooled RR estimates were of the order of 1.1–1.3 for high level of
alcohol intake, and residual bias and confounding by diet or other
factors is plausible. Inference on a potential causal relationship
for these cancer sites is therefore not possible. 
The present meta-analysis confirms the existence of a strong
dose–risk relation between alcohol and breast cancer risk
(Longnecker, 1994). For breast and other hormone-related
neoplasm (ovary, endometrium), a role of alcohol on female
hormone metabolism and serum levels is plausible (Longnecker,
1994; Dorgan et al, 2001). 
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Figure 1 Relative risk functions, and corresponding 95% confidence intervals, describing the dose–response relationship between alcohol consumption and
the risk of the 9 neoplasms showing statistical evidence of alcohol effect 1704 V Bagnardi et al 
British Journal of Cancer (2001) 85(11), 1700–1705 © 2001 Cancer Research Campaign
Alcohol and tobacco interact in a multiplicative way on the risk
of cancers of the upper digestive tract. From a public health view-
point, such a synergism implies that over 75% of cancers of the
upper digestive and respiratory tract in developed countries are
attributable to alcohol and tobacco (Negri et al, 1992, 1993; Tavani
et al, 1996). While the evidence is inconsistent for laryngeal
cancer, the adjusted pooled estimates confirm that for oral and
pharyngeal (Talamini et al, 1998; Fioretti et al, 1999) and
oesophageal cancers (Doll et al, 1999) alcohol drinking has an
independent effect, and hence allowance for tobacco only margin-
ally modified the RR. 
Several attempts have been made to separate the effects of
different types of alcoholic beverages. Some authors reported no
apparent differences, while others have reported greater risks with
spirits than with wine or beer (Tuyns et al, 1979; Doll et al, 1999).
Whereas a study from Denmark showed no excess risk from wine
(Gronbaek et al, 1998), 2 studies from Italy (Barra et al, 1990;
Bosetti et al, 2000) found greater risks of oral and pharyngeal and
oesophageal cancer in wine drinkers, after adjustment for amount
drunk. It appears, therefore, that the most frequently consumed
beverage in each area tends to be the one with the highest associa-
tion (Franceschi et al, 1990). For this reason, we have considered
only total alcohol consumption in the present overview. 
Notwithstanding the limitations discussed above, this meta-
analysis still includes most published information on alcohol and
cancer, and consequently – in the absence of a collaborative re-
analysis of original data with separation of abstainers and ex-
drinkers, and the inclusion of data for the whole range of cancers
in cohort studies – provides the most accurate relative risk esti-
mates for most common neoplasms that is available. Some of the
findings from this meta-analysis are innovative and of specific
relevance, including the absence of a threshold effect for any of
major alcohol-related cancer sites, and the apparently stronger
association for oral and pharyngeal cancer than for any other site
across different levels of alcohol drinking. 
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